Wilson disease and canine copper toxicosis

American Journal of Clinical Nutrition

Volumn 67, Issue 5 SUPPL., 1998, Pages

  Brewer, George J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; ZINC;

CONFERENCE PAPER; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; DNA DETERMINATION; GENE MUTATION; HUMAN; LIVER TOXICITY; MOLECULAR CLONING; WILSON DISEASE;

EID: 0031981413     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/67.5.1087S     Document Type: Conference Paper

References (36)

1. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine 1992;71:139-64.
2. Scheinberg IH, Sternlieb I. Wilson's disease. In: Smith LH Jr, ed. Major problems in internal medicine. Vol 23. Philadelphia: WB Saunders Company, 1984.
3. Brewer GJ, Yuzbasiyan-Gurkan V, Dick R. Zinc therapy of Wilson's disease. VIII. Dose response studies. J Trace Elem Exp Med 1990;3:227-43.
4. Cartwright GE, Wintrobe MM. Copper metabolism in normal subjects. Am J Clin Nutr 1964;14:224-32.
5. Frommer DJ. Defective biliary excretion of copper in Wilson's disease. Gut 1974;15:125-9.
6. O'Reilly S, Weber PM, Oswald, Shipley L. Abnormalities of the physiology of copper in Wilson's disease. III. The excretion of copper. Arch Neurol 1971;25:28-32.
7. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Comm 1993;197:271-7.
8. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993;5:327-37.
9. Tanzi RE, Petrukhin K, Chemov I, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993;5:344-50.
10. Figus A, Angius A, Loudianos G, et al. Molecular pathology and haplotype analysis of Wilson disease in Mediterranean populations. Hum Genet 1995;57:1318-24.
11. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995;9:210-7.
12. Sternlieb I, Scheinberg IH. Prevention of Wilson's disease in asymptomatic patients. N Engl J Med 1968;278:352-9.
13. Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, Johnson V, Wang Y. Treatment of Wilson's disease with zinc. XIII. Therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med 1994;123:849-58.
14. Walshe JM. Penicillamine. A new oral therapy for Wilson's disease. Am J Med 1956;21:487-95.
15. Walshe JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982;1:643-7.
16. Hoogenraad TU, Koevoet R, De Ruyter Korver EGW. Oral zinc sulfate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 1979;18:205-11.
17. Hoogenraad TU, Van den Hamer CJA, Koevoet R, De Ruyter Korver EGWM. Oral zinc in Wilson's disease. Lancet 1978;2:1262-3.
18. Hoogenraad TU, Van Hattum J, Van den Hamer CJA. Management of Wilson's disease with zinc sulfate. Experience in a series of 27 patients. J Neurol Sci 1987;77:137-46.
19. Yuzbasiyan-Gurkan V, Grider A, Nostrant T, Cousins RJ, Brewer GJ. The treatment of Wilson's disease with zinc. X. Intestinal metallothionein induction. J Lab Clin Med 1992;120:380-6.
20. Brewer GJ, Yuzbasiyan-Gurkan V, Johnson V, Dick RD, Wang Y. Treatment of Wilson's disease with zinc. XI. Interaction with other anticopper agents. J Am Coll Nutr 1993;12:26-30.
21. Brewer GJ, Yuzbasiyan-Gurkan V, Johnson V, Dick RD, Wang Y, Treatment of Wilson's disease with zinc. XII. Dose regimen requirements. Am J Med Sci 1993;305:199-202.
22. Hall AC, Young BW, Bremner I. Intestinal metallothionein and the mutual antagonism between copper and zinc in the rat. J Inorg Biochem 1979;11:57-66.
23. Menard MP, McCormick CC, Cousins RJ. Regulation of intestinal metallothionein biosynthesis in rats by dietary zinc. J Nutr 1981;111:1351-61.
24. Oestreicher P, Cousins RJ. Copper and zinc absorption in the rat: mechanism of mutual antagonism. J Nutr 1985;115:159-66.
25. Food and Drug Administration. Teratologic evaluation of FDA 71-49 (zinc sulfate). Bethesda, MD: Food and Drug Research Laboratories, Inc, 1973-1974. (US Department of Commerce publications PD-221 805 and PB 267.)
26. Nazer H, Ede RJ, Mowat AP, Williams R. Wilson's disease: clinical presentation and use of prognostic index. Gut 1986;27:1377-81.
27. Lee D-Y, Brewer GJ, Wang Y. Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc- induced metallothionein in a rat model. J Lab Clin Med 1989;114:639-45.
28. Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 1987;44:490-3.
29. Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, Tankanow R, Young AB, Kluin KJ. Initial therapy of Wilson's disease patients with tetrathiomolybdate. Arch Neurol 1991;48:42-7.
30. Brewer GJ, Dick RD, Johnson V, et al. Treatment of Wilson's disease with tetrathiomolybdate I. Initial therapy in 17 neurologically affected patients. Arch Neurol 1994;51:545-54.
31. Brewer GJ, Johnson V, Dick RD, Kluin KJ, Fink JK, Brunberg JA. Treatment of Wilson's disease with ammonium tetrathiomolybdate. II. Initial therapy in 33 neurologically affected patients and followup on zinc therapy. Arch Neurol 1996;53:1017-25.
32. Bremner I, Mills CF, Young BW. Copper metabolism in rats given di- or trithiomolybdates. J Inorg Biochem 1982;16:109-19.
33. Gooneratne SR, Howell JM, Gawthorne JM. An investigation of the effects of intravenous administration of thiomolybdate on copper metabolism in chronic Cu-poisoned sheep. Br J Nutr 1981;46:469-80.
34. Yuzbasiyan-Gurkan V, Wagnitz S, Halloran Blanton S, Brewer GJ. Linkage studies of the esterase D and retinoblastoma genes to canine copper toxicosis: a model for Wilson disease. Genomics 1992;15:86-90.
35. Yuzbasiyan-Gurkan V, Halloran Blanton S, Cao Y, et al. Linkage of a microsatellite marker to the canine copper toxicosis gene in the Bedlington terrier. Am J Vet Res 1997;58:23-7.
36. Brewer GJ, Dick RD, Schall W, et al. Use of zinc acetate to treat copper toxicosis in dogs. J Am Vet Med Assoc 1992;201:564-8.